Analyst Activity – Laidlaw Reiterates Hold on Intercept Pharmaceuticals (NASDAQ:ICPT)

ME Staff
-
0

Analyst Ratings For Intercept Pharmaceuticals (NASDAQ:ICPT)

Today, Laidlaw reiterated its Hold rating on Intercept Pharmaceuticals (NASDAQ:ICPT) with a price target of $119.00.

There are 2 sell ratings, 4 hold ratings, 10 buy ratings on the stock.

The current consensus rating on Intercept Pharmaceuticals (NASDAQ:ICPT) is Buy (Score: 2.50) with a consensus target price of $203.79 per share, a potential 83.99% upside.

Some recent analyst ratings include

  • 8/1/2017-Laidlaw Reiterated Rating of Hold.
  • 8/1/2017-Oppenheimer Holdings, Inc. Reiterated Rating of Outperform.
  • 7/31/2017-Wedbush Reiterated Rating of Buy.
  • 7/31/2017-Cantor Fitzgerald Reiterated Rating of Underweight.
  • 7/30/2017-Jefferies Group LLC Reiterated Rating of Buy.
  • 6/12/2017-Cowen and Company Reiterated Rating of Buy.

Recent Insider Trading Activity For Intercept Pharmaceuticals (NASDAQ:ICPT)
Intercept Pharmaceuticals (NASDAQ:ICPT) has insider ownership of 4.50% and institutional ownership of 84.27%.

  • On 7/20/2017 Daniel G Welch, Director, sold 217 with an average share price of $126.76 per share and the total transaction amounting to $27,506.92. View SEC Filing
  • On 7/14/2017 Richard J Kim, SVP, sold 89 with an average share price of $128.64 per share and the total transaction amounting to $11,448.96. View SEC Filing
  • On 7/11/2017 David Shapiro, CMO, sold 553 with an average share price of $124.01 per share and the total transaction amounting to $68,577.53. View SEC Filing
  • On 7/3/2017 David Shapiro, CMO, sold 350 with an average share price of $121.24 per share and the total transaction amounting to $42,434.00. View SEC Filing
  • On 7/3/2017 Lisa Bright, Insider, sold 394 with an average share price of $121.33 per share and the total transaction amounting to $47,804.02. View SEC Filing
  • On 7/3/2017 Mark Pruzanski, CEO, sold 1,434 with an average share price of $121.78 per share and the total transaction amounting to $174,632.52. View SEC Filing
  • On 7/3/2017 Richard J Kim, SVP, sold 50 with an average share price of $121.69 per share and the total transaction amounting to $6,084.50. View SEC Filing

Recent Trading Activity for Intercept Pharmaceuticals (NASDAQ:ICPT)
Shares of Intercept Pharmaceuticals closed the previous trading session at 110.76 down -6.37 -5.44% with 1,763,421 shares trading hands.